The American Hospital Association (AHA) expresses support for the Home Health Stabilization Act of 2025 (H.R. 5142).

The AHA expressed support Nov. 3 for the bipartisan Home Health Stabilization Act (H.R. 5142), legislation that would establish a two-year pause on planned cuts to home health services from the ...

The AHA’s Division of Health Outcomes and Care Transformation will host a webinar Nov. 10 at 2 p.m. ET, where experts will share strategies to integrate health outcome priorities into strategic plans ...

The AHA commented Nov. 3 on the Centers for Medicare & Medicaid Services’ calendar year 2026 final rule for the physician fee schedule. The rule, released Oct. 31, increases the qualifying alternative ...

Bill Gassen, Sanford Health president and CEO and AHA chair-elect designate, and Deb Koski, Sanford Health chief philanthropy officer, discuss how a strong culture of giving is extending world-class ...

In this conversation, Sanford Health's Bill Gassen, president and CEO, and Deb Koski, chief philanthropy officer, discuss how a strong culture of giving is extending world-class care across rural ...

The Centers for Medicare & Medicaid Services Oct. 31 released its calendar year 2026 final rule for the physician fee schedule.

The AHA and a coalition of organizations urged House and Senate leaders to pass the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act (S. 2761/H.R. 5269).

Individuals and families can enroll in or change their health coverage options through the Health Insurance Marketplace beginning tomorrow through Jan. 15. The AHA offers resources to help people ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety Convening in Little Rock, Ark., Oct. 6-8.

Growing strategic competition between China and the West – particularly the United States – will increasingly play out in the biotechnology and pharmaceutical industries, and when coupled with AI’s ...